DUBLIN, February 28, 2014 /PRNewswire/ --
Dublin - Research and Markets (http://www.researchandmarkets.com/research/62423g/aptamers_market) has announced the addition of the "Concise Analysis of the International Aptamers Market Technology Trend Analysis - Forecasts to 2018" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The global aptamers market is anticipated to reach $2.1 billion by 2018 growing at a CAGR of 49.24%. The aptamers market is divided by geography (North America, Europe, Asia-Pacific and Rest of the World), application segments (therapeutics, diagnostics, biosensors, drug discovery, biomarker discovery, and research applications) and aptamer type (Nucleic acid aptamers and Peptide aptamers). Further each application segment and the aptamer type is broken down by geography, with exhaustive revenue analysis for the entire forecast period. Of the above mentioned application segments, research applications is the largest revenue segment; however, biomarker discovery and diagnostics will be the fastest-growing segment.
The potential growth of the market is attributed to future diagnostics, drug discovery and research applications. The future approval of a few diagnostic tests specifically for infectious diseases and a couple of drugs in the market will greatly propel the market. The global market for aptamers is expected to grow, backed by technological advancements with respect to selection processes and synthesis. The market will experience continuous improvements in aptamer synthesis and its applicability in drug discovery and routine research. The market is witnessing a trend toward development of personalized medicine and point-of-care diagnostic tests. Additionally, the demand for safe and cost-effective drugs for treatment of cancer (which can be fulfilled by aptamer therapeutics), will remarkably fuel market growth.
North America is a significant contributor to the market, followed by Europe, due to the presence of technology providers and better R&D facilities. The new markets that are expected to grow at a brisk pace are emerging economics such as China, India, Japan and other regions of Asia-Pacific and untapped markets of Europe due to their growing GDP, healthcare costs, and rising demand for safe and cost-effective diagnostics and therapeutics.
Key players in this market are AM Biotechnologies, LLC (U.S.), Aptagen, LLC (U.S.), Aptamer Sciences Inc. (South Korea), Aptamer Solutions Ltd (U.K.), Base Pair Biotechnologies (U.S.), Bioapter S.L. (Spain), Integrated Biotechnologies, Inc. (U.S.), NOXXON Pharma AG (Germany), OTC Biotech (U.S.), Regado Biosciences, Inc. (U.S.), Somalogic, Inc. (U.S.), and TriLink BioTechnologies, Inc. (U.S.).
Key Topics Covered:
2 Executive Summary
3 Aptamers - Technology Landscape Analysis
4 Aptamers - Market Landscape Analysis
5 Technology Investment Potential
6 Aptamers - Technology Adoption And Development Potential
7 Aptamers Competitive Landscape
8 Intellectual Property And Research Strength Analysis
9 Analyst Insights And Recommendations
10 Company Profiles
- AM Biotechnologies, Llc
- Aptagen, LIC
- Aptamatrix, Inc
- Aptamer Sciences Inc
- Aptamer Solutions Ltd
- Aptares AG
- Base Pair Biotechnologies
- Bioapter SL
- Cd Genomics
- Integrated Dna Technologies, Inc
- Lucerna, Inc
- NOXXON Pharma AG
- Neoventures Biotechnology Inc
- OTC Biotech
- Ophthotech Corporation
- Regado Biosciences, Inc
- Somalogic, Inc
- Trilink Biotechnologies, Inc
For more information visit http://www.researchandmarkets.com/research/62423g/aptamers_market
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets